For the quarter ending 2026-03-31, BDSX made $25,555K in revenue. -$7,793K in net income. Net profit margin of -30.50%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 25,555 | 28,755 | 21,768 | 20,018 |
| Direct costs and expenses | 4,205 | 4,879 | 4,106 | 4,031 |
| Research and development | 3,285 | 2,870 | 2,992 | 3,269 |
| Sales, marketing, general and administrative | 24,261 | 22,972 | 21,714 | 22,411 |
| Impairment loss on intangible assets | 5 | 1 | 7 | 26 |
| Total operating expenses | 31,756 | 30,722 | 28,819 | 29,737 |
| Loss from operations | -6,201 | -1,967 | -7,051 | -9,719 |
| Interest expense | 1,977 | 2,059 | 2,074 | 1,898 |
| Change in fair value of warrant liability, net | - | -140* | - | -98 |
| Other income , net | - | -94* | - | - |
| Other income, net | 385 | - | 409 | 51 |
| Total other expense | -1,592 | -2,013 | -1,665 | -1,749 |
| Net loss | -7,793 | -3,980 | -8,716 | -11,468 |
| Basic EPS | -0.81 | -0.527 | -1.16 | -0.08 |
| Diluted EPS | -0.81 | -0.527 | -1.16 | -0.08 |
| Basic Average Shares | 9,656,000 | 7,551,000* | 7,500,000 | 146,656,000 |
| Diluted Average Shares | 9,656,000 | 7,551,000* | 7,500,000 | 146,656,000 |
BIODESIX INC (BDSX)
BIODESIX INC (BDSX)